CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX.
Front Immunol
; 13: 1050250, 2022.
Article
in En
| MEDLINE
| ID: mdl-36713447
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Poxviridae
/
Neoplasms
Limits:
Animals
/
Humans
Language:
En
Journal:
Front Immunol
Year:
2022
Document type:
Article
Affiliation country:
Canadá